Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of Weighted-Average Assumptions Used in BSM Model to Calculate Fair Value of Options

The following table sets forth the key weighted-average assumptions used in the BSM Model to calculate the fair value of options:

	SUCCESSOR						PREDECESSOR
	Year Ended		Year Ended		Period Ended		Period Ended
	December 31,		December 31,		December 31,		March 31,
	2016		2015		2014		2014
Expected holding period - years	3.6		4.2		5.4		N/A
Expected volatility		30.2%		36.4%		41.8%	N/A
Risk-free interest rate		1.0%		1.2%		1.7%	N/A
Expected dividend yield		0.0%		0.0%		0.0%	N/A

Schedule of Grant Date Fair Value and Stock-based Compensation Expense Allocated

The following table summarizes the grant date fair values of stock options and restricted shares issued during the period as well as the allocation of stock-based compensation expense to Direct costs, excluding depreciation and amortization, and Selling, general and administrative reported in the consolidated statements of operations:

	SUCCESSOR						PREDECESSOR
	Year Ended		Year Ended		Period Ended		Period Ended
	December 31,		December 31,		December 31,		March 31,
	2016		2015		2014		2014
Weighted average, grant date fair value
Stock Options	$	6.91	$	3.81	$	4.33	N/A
Restricted shares (RSAs and RSUs)	$	15.08	$	12.53	$	10.80	N/A

Stock-based compensation expense allocated to:
Direct costs, excluding depreciation and amortization	$	5,555	$	9,243	$	4,399	$	5,422
Selling, general, and administrative		4,260		13,081		1,024		1,918
Total stock-based compensation expense	$	9,815	$	22,324	$	5,423	$	7,340

Schedule of Successor and Predecessor's Stock Option Activity

The following table sets forth the Successor’s and Predecessor’s stock option activity:

	SUCCESSOR															PREDECESSOR
	Year Ended					Year Ended					Period Ended					Period Ended
	December 31,					December 31,					December 31,					March 31,
	2016					2015					2014					2014
				Weighted Average					Weighted Average					Weighted Average					Weighted Average
	Options			Exercise Price		Shares			Exercise Price		Shares			Exercise Price		Shares			Exercise Price
Outstanding - beginning of Period		1,794,709		$	15.42		1,091,048		$	14.40		-		$	-		1,438,800		$	11.03
Granted		683,001		$	22.80		889,849		$	16.67		1,131,895		$	14.40		-		$	-
Exercised		(36,980	)	$	-		(17,404	)	$	-		-		$	-		(1,388,000	)	$	10.97
Forfeited		(90,564	)	$	15.85		(168,784	)	$	15.53		(40,847	)	$	14.40		(32,200	)	$	12.53
Expired		-		$	-		-		$	-		-		$	-		(18,600	)	$	11.27
Outstanding - end of period		2,350,166		$	17.57		1,794,709		$	15.42		1,091,048		$	14.40		-		$	-

Exercisable - end of period		647,343		$	15.22		242,777		$	14.40		-		$	-		-		$	-

Schedule of Successor and Predecessor's Restricted Share Activity

The following table sets forth the Successor and Predecessor’s Restricted Share activity:

	SUCCESSOR									PREDECESSOR
	Year Ended			Year Ended			Period Ended			Period Ended
	December 31,			December 31,			December 31,			March 31,
	2016			2015			2014			2014
	Shares			Shares			Shares			Shares
Outstanding and unvested - beginning of period		90,697			407,171			-			176,643
Granted		11,111			1,253,924			707,721			-
Vested		(41,069	)		(1,530,547	)		(283,042	)		(172,492	)
Forfeited		(1,481	)		(39,851	)		(17,508	)		(4,151	)
Outstanding and unvested - end of period		59,258			90,697			407,171			-

Cumulative vested shares - end of period		1,854,658			1,813,589			283,042			263,490

Schedule of Stock Options Expected To Vest, Stock Options Exercisable, and Unvested Restricted Share Awards Expected To Vest

The following table summarizes information about stock options expected to vest, stock options exercisable, and unvested restricted share awards expected to vest at December 31, 2016:

	Weighted Average						Weighted Average
	Exercise		Stock		Restricted		Remaining
Issued in Successor Year Ended	Price		Options		Shares		Life (Years)
December 31, 2016
Number of stock options expected to vest	$	17.51		2,304,229		-		5.4
Number of Restricted Shares expected to vest				-		59,258
Total expected to vest - December 31, 2016				2,304,229		59,258
Total stock options exercisable - December 31, 2016	$	15.22		647,343				4.8
Unrecognized compensation cost - December 31, 2016 (in thousands)			$	7,909	$	538
Weighted average years over which unrecognized compensation cost will be recognized				2.4		2.0

Schedule of Aggregate Intrinsic Value of Stock Options Exercised, Fair Values of Awards Vested, and Share Based Liabilities Settled

The following table sets forth the aggregate intrinsic value of stock options exercised, the fair values of awards vested, and share based liabilities settled during the respective periods (in thousands):

	SUCCESSOR							PREDECESSOR
	Year Ended		Year Ended			Period Ended		Period Ended
	December 31,		December 31,			December 31,		March 31,
	2016		2015			2014		2014
Total intrinsic value of stock options exercised	$	403	$	(36	)	$	-	$	25,378
Total grant-date fair value of stock options vested	$	1,384	$	1,168		$	-	$	3,446
Total grant-date fair value of restricted shares vested	$	614	$	18,284		$	3,057	$	1,466
Total settlement date fair value of restricted shares vested	$	1,236	$	21,134		$	3,057	N/A
Total share-based liabilities settled	$	76	$	16,858		$	3,057	N/A